Please use this identifier to cite or link to this item: https://hdl.handle.net/1959.11/53761
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBrown, Stephen Len
dc.contributor.authorFisher, Peteren
dc.contributor.authorHope-Stone, Lauraen
dc.contributor.authorDamato, Bertilen
dc.contributor.authorHeimann, Heinrichen
dc.contributor.authorHussain, Rumanaen
dc.contributor.authorCherry, M Gemmaen
dc.date.accessioned2022-12-05T00:06:47Z-
dc.date.available2022-12-05T00:06:47Z-
dc.date.issued2023-
dc.identifier.citationJournal of Cancer Survivorship, v.17, p. 187-196en
dc.identifier.issn1932-2267en
dc.identifier.issn1932-2259en
dc.identifier.urihttps://hdl.handle.net/1959.11/53761-
dc.description.abstract<p><b>Objective</b> The fear of cancer recurrence (FCR) in later survivorship can lead to poorer mental health, quality of life and physical and functional recovery. Later-occurring FCR may be a consequence of late-emerging physical symptoms and functional problems from cancer or its treatment. Based on the self-regulation model, we predicted that persistent or escalating symptoms and functional problems would prospectively predict FCR observed 2–5 years after diagnosis and treatment.</p> <p><b>Methods</b> This is a fve-year study of 708 uveal melanoma (UM) patients, measuring self-reported visual and ocular symptoms, functional problems and FCR at 6, 12, 24, 36, 48 and 60 months post-diagnosis. A mixed measures design over four levels with observations staggered to represent prospective prediction. Criterion variables were FCR at 24, 36, 48 and 60 months. Predictors were symptom and function scores measured at the previous two observations to FCR. Controls were FCR measured at the previous observation to the criterion FCR measure and demographic, clinical and treatment variables.</p> <p><b>Results</b> Linear mixed modelling showed that FCR was uniquely predicted by enduring symptoms, those that emerged two observations previously, but not symptoms arising at the previous observation. FCR was predicted by functional problems, which emerged in the observation prior to FCR, but not the observation previous to that.</p> <p><b>Conclusions</b> Persistent or emerging post-treatment symptoms and functional limitations are probable risk factors for lateoccurring FCR in UM survivors.</p> <p><b>Implications</b> for Cancer Survivors Monitoring symptoms and functional limitations assists in identifying at-risk survivors and targeting preventive interventions. Self-regulation theory suggests that helping survivors to more realistically appraise symptoms and functional problems may prevent FCR.</p>en
dc.languageenen
dc.publisherSpringer New York LLCen
dc.relation.ispartofJournal of Cancer Survivorshipen
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleFear of cancer recurrence and adverse cancer treatment outcomes: predicting 2- to 5-year fear of recurrence from post-treatment symptoms and functional problems in uveal melanoma survivorsen
dc.typeJournal Articleen
dc.identifier.doi10.1007/s11764-021-01129-0en
local.contributor.firstnameStephen Len
local.contributor.firstnamePeteren
local.contributor.firstnameLauraen
local.contributor.firstnameBertilen
local.contributor.firstnameHeinrichen
local.contributor.firstnameRumanaen
local.contributor.firstnameM Gemmaen
local.profile.schoolSchool of Psychologyen
local.profile.emailsbrow238@une.edu.auen
local.output.categoryC1en
local.record.placeauen
local.record.institutionUniversity of New Englanden
local.publisher.placeUnited States of Americaen
local.format.startpage187en
local.format.endpage196en
local.peerreviewedYesen
local.identifier.volume17en
local.title.subtitlepredicting 2- to 5-year fear of recurrence from post-treatment symptoms and functional problems in uveal melanoma survivorsen
local.contributor.lastnameBrownen
local.contributor.lastnameFisheren
local.contributor.lastnameHope-Stoneen
local.contributor.lastnameDamatoen
local.contributor.lastnameHeimannen
local.contributor.lastnameHussainen
local.contributor.lastnameCherryen
dc.identifier.staffune-id:sbrow238en
local.profile.orcid0000-0002-6142-0995en
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.identifier.unepublicationidune:1959.11/53761en
local.date.onlineversion2021-11-30-
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
dc.identifier.academiclevelAcademicen
local.title.maintitleFear of cancer recurrence and adverse cancer treatment outcomesen
local.output.categorydescriptionC1 Refereed Article in a Scholarly Journalen
local.search.authorBrown, Stephen Len
local.search.authorFisher, Peteren
local.search.authorHope-Stone, Lauraen
local.search.authorDamato, Bertilen
local.search.authorHeimann, Heinrichen
local.search.authorHussain, Rumanaen
local.search.authorCherry, M Gemmaen
local.uneassociationNoen
local.atsiresearchNoen
local.sensitive.culturalNoen
local.year.available2021en
local.year.published2023en
local.fileurl.closedpublishedhttps://rune.une.edu.au/web/retrieve/dbea235b-6b16-4859-ae77-8788f8fb6fd3en
local.subject.for2020520302 Clinical psychologyen
local.subject.seo2020130301 Bioethicsen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
local.profile.affiliationtypeExternal Affiliationen
Appears in Collections:Journal Article
School of Psychology
Files in This Item:
2 files
File Description SizeFormat 
Show simple item record

SCOPUSTM   
Citations

11
checked on Jan 11, 2025

Page view(s)

218
checked on Mar 9, 2023

Download(s)

2
checked on Mar 9, 2023
Google Media

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons